Considerations When Implementing Medication-Assisted Treatment for Opioid Dependent Patients

Medication-assisted treatment (MAT) for opioid addiction needs all the support it can get. Although state laws increasingly encourage MAT at the same time Suboxone®/buprenorphine waiver limits have expanded, only 1 in 20 active licensed physicians is approved to provide it.*

This whitepaper answers common questions doctors have about MAT, including:

  • Qualifications for a Suboxone®/buprenorphine waiver
  • Evaluating medical necessity for treatment
  • Tests: comparing point of care vs. lab-performed
  • Digital methods to support recovery
Download Supplement

* Young A, Chaudhry HJ, Pei X, Arnhart K, Dugan M, Snyder GB. A Census of Actively Licensed Physicians in the United States, 2016. Jour Med Reg. 103; 2:7-21. 2017 / Physician and Program Data. Substance Abuse and Mental Health Services Administration Web site. https://www.samhsa.gov/medication-assisted-treatment/ physician-program-data/. Accessed May 17, 2018

 

Related Videos
Jolie Apicella, JD
Jolie Apicella, JD
Jolie Apicella, JD
Jolie Apicella, JD
Jolie Apicella, JD
Jolie Apicella, JD
Jolie Apicella, JD
Beth Lown, MD
Beth Lown, MD
Related Content
© 2023 MJH Life Sciences

All rights reserved.